ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)

Anthropic acquired Mithril Medicine, a one-person startup, to run in-house drug discovery programs for muscular dystrophy. The company collaborates with six partners, including Bristol Myers Squibb, using AI to engineer therapies. Preliminary findings show mice treated with one design grew twice as strong in grip. If candidates succeed, a drug could enter human trials by late 2028.
Tap to vote and see what everyone thinks.
Summary by ByteBrief